31225769|t|Aster glehni Extract Ameliorates Scopolamine-Induced Cognitive Impairment in Mice.
31225769|a|The leaves of Aster glehni Fr. Schm. (Asteraceae) have been used to treat insomnia in Korea. Insomnia is a common adverse effect of therapeutic agents for Alzheimer's disease (AD), and the control of sleep disturbance may prevent dementia. We hypothesized that the leaves of A. glehni can attenuate cognitive dysfunctions observed in AD. We observed the ameliorating effects of the ethanolic extract of leaves of A. glehni (AG-D) on memory dysfunction through the Morris water maze test, the passive avoidance test, and the Y-maze test. We performed acetylcholinesterase (AChE) activity assay and Western blotting to determine the mechanism of action of AG-D. AG-D significantly attenuated memory dysfunction observed in the above behavior studies and inhibited the activity of AChE. AG-D also increased the levels of phosphorylation extracellular signal-regulated kinase (ERK), cAMP response element-binding protein (CREB), phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), and glycogen synthase kinase 3beta (GSK-3beta) and the expression levels of brain-derived neurotrophic factor (BDNF) in the hippocampi. These results suggest that AG-D ameliorates memory impairments by AChE inhibition and activation of ERK-CREB-BDNF and PI3K-Akt-GSK-3beta signaling pathways. Taken together, this study suggests that AG-D could be used as a potential treatment for cognitive dysfunction.
31225769	0	20	Aster glehni Extract	Chemical	-
31225769	21	32	Ameliorates	Chemical	-
31225769	33	44	Scopolamine	Chemical	MESH:D012601
31225769	53	73	Cognitive Impairment	Disease	MESH:D003072
31225769	77	81	Mice	Species	10090
31225769	97	109	Aster glehni	Species	
31225769	157	165	insomnia	Disease	MESH:D007319
31225769	176	184	Insomnia	Disease	MESH:D007319
31225769	238	257	Alzheimer's disease	Disease	MESH:D000544
31225769	259	261	AD	Disease	MESH:D000544
31225769	283	300	sleep disturbance	Disease	MESH:D012893
31225769	313	321	dementia	Disease	MESH:D003704
31225769	358	367	A. glehni	Species	
31225769	382	404	cognitive dysfunctions	Disease	MESH:D003072
31225769	417	419	AD	Disease	MESH:D000544
31225769	475	505	extract of leaves of A. glehni	Chemical	-
31225769	507	511	AG-D	Chemical	-
31225769	516	534	memory dysfunction	Disease	MESH:D008569
31225769	633	653	acetylcholinesterase	Gene	11423
31225769	655	659	AChE	Gene	11423
31225769	737	742	AG-D.	Chemical	-
31225769	743	747	AG-D	Chemical	-
31225769	773	791	memory dysfunction	Disease	MESH:D008569
31225769	861	866	AChE.	Gene	11423
31225769	867	871	AG-D	Chemical	-
31225769	917	954	extracellular signal-regulated kinase	Gene	26413
31225769	956	959	ERK	Gene	26413
31225769	962	999	cAMP response element-binding protein	Gene	12912
31225769	1001	1005	CREB	Gene	12912
31225769	1008	1037	phosphatidylinositol 3-kinase	Gene	18708
31225769	1064	1067	Akt	Gene	11651
31225769	1074	1104	glycogen synthase kinase 3beta	Gene	56637
31225769	1106	1115	GSK-3beta	Gene	56637
31225769	1146	1179	brain-derived neurotrophic factor	Gene	12064
31225769	1181	1185	BDNF	Gene	12064
31225769	1233	1237	AG-D	Chemical	-
31225769	1238	1249	ameliorates	Chemical	-
31225769	1250	1268	memory impairments	Disease	MESH:D008569
31225769	1272	1276	AChE	Gene	11423
31225769	1306	1309	ERK	Gene	26413
31225769	1310	1314	CREB	Gene	12912
31225769	1315	1319	BDNF	Gene	12064
31225769	1329	1332	Akt	Gene	11651
31225769	1333	1342	GSK-3beta	Gene	56637
31225769	1404	1408	AG-D	Chemical	-
31225769	1452	1473	cognitive dysfunction	Disease	MESH:D003072
31225769	Association	MESH:D008569	12912
31225769	Positive_Correlation	MESH:D012601	MESH:D003072
31225769	Association	MESH:D008569	11651
31225769	Association	MESH:D008569	26413
31225769	Association	MESH:D008569	56637

